Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

55.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.9K
Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

11.0K
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
11.0K
Next-generation Sequencing03:00

Next-generation Sequencing

87.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.2K
Mismatch Repair01:36

Mismatch Repair

39.9K
Overview
39.9K
Alternative RNA Splicing02:18

Alternative RNA Splicing

20.9K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.9K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sunlight Activated, Film Forming Polymer Based on Diazirine Grafted Polycaprolactone.

ACS applied bio materials·2026
Same author

Multispecific nanobody degraders co-deplete membrane receptors and enable targeted delivery of diverse payloads.

bioRxiv : the preprint server for biology·2026
Same author

Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.

eLife·2026
Same author

Lineage-Specific Venom Gene Expression Shapes Chemical Diversity in Cephalopods.

bioRxiv : the preprint server for biology·2026
Same author

Design, Synthesis, and Application of Sulfonium Diazo Probes for Red-Light Photocatalytic Proximity Labeling.

ACS chemical biology·2026
Same author

Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer.

Nature communications·2026

Related Experiment Video

Updated: May 28, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.9K

Unveiling sequence-agnostic mixed-chemical modification patterns for splice-switching oligonucleotides using the

Tommaso Tabaglio1, Taniya Agarwal1, Wei Yuan Cher1

  • 1Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore.

Molecular Therapy. Nucleic Acids
|February 10, 2025
PubMed
Summary

New ribose modifications enhance splice-switching oligonucleotides (SSOs) potency. A novel platform, NATURA, quantifies these enhancements, accelerating the development of nucleic acid therapeutics (NATs).

Keywords:
MT: Oligonucleotides: Therapies and Applicationsantisense oligonucleotidesmixmersnucleic acid chemical modificationsnucleic acid therapeuticsreporter systemsplice modulationsplice-switching oligonucleotides

More Related Videos

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
05:33

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Published on: July 5, 2024

564
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

4.8K

Related Experiment Videos

Last Updated: May 28, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

8.9K
Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
05:33

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Published on: July 5, 2024

564
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

4.8K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Development

Background:

  • Chemical modifications of ribose have improved nucleic acid therapeutics (NATs) stability and efficacy.
  • Splice-switching oligonucleotides (SSOs) are a class of NATs targeting RNA splicing.
  • Optimizing SSO modifications is crucial for enhancing their therapeutic potential.

Purpose of the Study:

  • To identify novel chemical modifications that enhance SSO potency.
  • To develop a high-throughput platform for quantifying SSO efficacy.
  • To accelerate the development and delivery of SSO-based therapies.

Main Methods:

  • Investigated mixed-modification patterns of ribose moieties (2'-O-Methyl, 2'-MethOxyEthyl, 2'-Locked Nucleic Acid, and 2'-Constrained Ethyl).
  • Developed and validated the NAT Unlabeled Reporter Assay (NATURA) for high-throughput quantification of NAT functional delivery and potency.
  • Tested SSO efficacy across various sequences using NATURA in a transgenic mouse model.

Main Results:

  • Identified specific mixed-modification patterns, termed lateral mixed positional configuration, that significantly enhance SSO potency.
  • Demonstrated improved SSO efficacy across diverse sequences using the novel modification strategy.
  • Validated NATURA as a reliable platform for assessing NAT potency and delivery.

Conclusions:

  • Lateral mixed positional configuration represents a promising strategy for enhancing SSO efficacy.
  • The NATURA platform accelerates the evaluation of NAT modifications and delivery methods.
  • These advancements can reduce trial-and-error in SSO development and facilitate NAT delivery to patients.